Daiichi Sankyo
Renee DePue possesses extensive experience in the pharmaceutical and healthcare industries, currently serving as Senior Associate Director for Oncology Accounts at Daiichi Sankyo US since October 2015. In previous roles at Daiichi Sankyo, Renee held positions such as Associate Director of Oncology Accounts-Market Access and Senior Oncology Territory Manager - Regional Sales Trainer. Prior to this, Renee co-owned Next Day Access and worked as a Territory Manager for Cardiology and Endocrinology Specialty at AbbVie. Early career experiences include serving as an Account Manager at Allegis Group and as a Vascular Research Assistant at The University of Tennessee Medical Center. Renee earned a Bachelor of Arts in Biology from Carson-Newman University and attended the University of Tennessee, Knoxville.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.